- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Metabolomics Biomarker market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Metabolomics Biomarker market. Detailed analysis of key players, along with key growth strategies adopted by Metabolomics Biomarker industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Creative Proteomics
Chenomx
Evotec
Biocrates Life Sciences
Ovid Therapeutics
Metabolon
Merck
Biomark Diagnostics
Human Metabolome Technologies
Metabolomic Diagnostics
By Type:
Gas chromatography
High-performance liquid chromatography
Ultra-performance liquid chromatography
Nuclear magnetic resonance
Mass spectrometry
Surface-based mass analysis
Bioinformatics
By End-User:
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Metabolomics Biomarker Market
-
1.3 Market Segment by Type
-
1.3.1 China Metabolomics Biomarker Market Size and Growth Rate of Gas chromatography from 2016 to 2027
-
1.3.2 China Metabolomics Biomarker Market Size and Growth Rate of High-performance liquid chromatography from 2016 to 2027
-
1.3.3 China Metabolomics Biomarker Market Size and Growth Rate of Ultra-performance liquid chromatography from 2016 to 2027
-
1.3.4 China Metabolomics Biomarker Market Size and Growth Rate of Nuclear magnetic resonance from 2016 to 2027
-
1.3.5 China Metabolomics Biomarker Market Size and Growth Rate of Mass spectrometry from 2016 to 2027
-
1.3.6 China Metabolomics Biomarker Market Size and Growth Rate of Surface-based mass analysis from 2016 to 2027
-
1.3.7 China Metabolomics Biomarker Market Size and Growth Rate of Bioinformatics from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Metabolomics Biomarker Market Size and Growth Rate of Toxicological studies from 2016 to 2027
-
1.4.2 China Metabolomics Biomarker Market Size and Growth Rate of Drug testing from 2016 to 2027
-
1.4.3 China Metabolomics Biomarker Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.4 China Metabolomics Biomarker Market Size and Growth Rate of Cardiovascular disorders from 2016 to 2027
-
1.4.5 China Metabolomics Biomarker Market Size and Growth Rate of Neurological disorders from 2016 to 2027
-
1.4.6 China Metabolomics Biomarker Market Size and Growth Rate of Inborn errors of metabolism from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Metabolomics Biomarker Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Metabolomics Biomarker by Major Types
-
3.4.1 Market Size and Growth Rate of Gas chromatography
-
3.4.2 Market Size and Growth Rate of High-performance liquid chromatography
-
3.4.3 Market Size and Growth Rate of Ultra-performance liquid chromatography
-
3.4.4 Market Size and Growth Rate of Nuclear magnetic resonance
-
3.4.5 Market Size and Growth Rate of Mass spectrometry
-
3.4.6 Market Size and Growth Rate of Surface-based mass analysis
-
3.4.7 Market Size and Growth Rate of Bioinformatics
4 Segmentation of Metabolomics Biomarker Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Metabolomics Biomarker by Major End-Users
-
4.4.1 Market Size and Growth Rate of Metabolomics Biomarker in Toxicological studies
-
4.4.2 Market Size and Growth Rate of Metabolomics Biomarker in Drug testing
-
4.4.3 Market Size and Growth Rate of Metabolomics Biomarker in Cancer
-
4.4.4 Market Size and Growth Rate of Metabolomics Biomarker in Cardiovascular disorders
-
4.4.5 Market Size and Growth Rate of Metabolomics Biomarker in Neurological disorders
-
4.4.6 Market Size and Growth Rate of Metabolomics Biomarker in Inborn errors of metabolism
5 Market Analysis by Regions
-
5.1 China Metabolomics Biomarker Production Analysis by Regions
-
5.2 China Metabolomics Biomarker Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Metabolomics Biomarker Landscape Analysis
-
6.1 North China Metabolomics Biomarker Landscape Analysis by Major Types
-
6.2 North China Metabolomics Biomarker Landscape Analysis by Major End-Users
7 Central China Metabolomics Biomarker Landscape Analysis
-
7.1 Central China Metabolomics Biomarker Landscape Analysis by Major Types
-
7.2 Central China Metabolomics Biomarker Landscape Analysis by Major End-Users
8 South China Metabolomics Biomarker Landscape Analysis
-
8.1 South China Metabolomics Biomarker Landscape Analysis by Major Types
-
8.2 South China Metabolomics Biomarker Landscape Analysis by Major End-Users
9 East China Metabolomics Biomarker Landscape Analysis
-
9.1 East China Metabolomics Biomarker Landscape Analysis by Major Types
-
9.2 East China Metabolomics Biomarker Landscape Analysis by Major End-Users
10 Northeast China Metabolomics Biomarker Landscape Analysis
-
10.1 Northeast China Metabolomics Biomarker Landscape Analysis by Major Types
-
10.2 Northeast China Metabolomics Biomarker Landscape Analysis by Major End-Users
11 Southwest China Metabolomics Biomarker Landscape Analysis
-
11.1 Southwest China Metabolomics Biomarker Landscape Analysis by Major Types
-
11.2 Southwest China Metabolomics Biomarker Landscape Analysis by Major End-Users
12 Northwest China Metabolomics Biomarker Landscape Analysis
-
12.1 Northwest China Metabolomics Biomarker Landscape Analysis by Major Types
-
12.2 Northwest China Metabolomics Biomarker Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Creative Proteomics
-
13.1.1 Creative Proteomics Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Chenomx
-
13.2.1 Chenomx Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Evotec
-
13.3.1 Evotec Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Biocrates Life Sciences
-
13.4.1 Biocrates Life Sciences Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Ovid Therapeutics
-
13.5.1 Ovid Therapeutics Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Metabolon
-
13.6.1 Metabolon Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Merck
-
13.7.1 Merck Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Biomark Diagnostics
-
13.8.1 Biomark Diagnostics Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Human Metabolome Technologies
-
13.9.1 Human Metabolome Technologies Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Metabolomic Diagnostics
-
13.10.1 Metabolomic Diagnostics Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Gas chromatography from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of High-performance liquid chromatography from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Ultra-performance liquid chromatography from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Nuclear magnetic resonance from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Mass spectrometry from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Surface-based mass analysis from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Bioinformatics from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Toxicological studies from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Drug testing from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Cardiovascular disorders from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Neurological disorders from 2016 to 2027
-
Figure China Metabolomics Biomarker Market Size and Growth Rate of Inborn errors of metabolism from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Metabolomics Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Metabolomics Biomarker Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Metabolomics Biomarker
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Metabolomics Biomarker by Different Types from 2016 to 2027
-
Table Consumption Share of Metabolomics Biomarker by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Gas chromatography
-
Figure Market Size and Growth Rate of High-performance liquid chromatography
-
Figure Market Size and Growth Rate of Ultra-performance liquid chromatography
-
Figure Market Size and Growth Rate of Nuclear magnetic resonance
-
Figure Market Size and Growth Rate of Mass spectrometry
-
Figure Market Size and Growth Rate of Surface-based mass analysis
-
Figure Market Size and Growth Rate of Bioinformatics
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Metabolomics Biomarker by Different End-Users from 2016 to 2027
-
Table Consumption Share of Metabolomics Biomarker by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Toxicological studies
-
Figure Market Size and Growth Rate of Drug testing
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Cardiovascular disorders
-
Figure Market Size and Growth Rate of Neurological disorders
-
Figure Market Size and Growth Rate of Inborn errors of metabolism
-
Table China Metabolomics Biomarker Production by Regions
-
Table China Metabolomics Biomarker Production Share by Regions
-
Figure China Metabolomics Biomarker Production Share by Regions in 2016
-
Figure China Metabolomics Biomarker Production Share by Regions in 2021
-
Figure China Metabolomics Biomarker Production Share by Regions in 2027
-
Table China Metabolomics Biomarker Consumption by Regions
-
Table China Metabolomics Biomarker Consumption Share by Regions
-
Figure China Metabolomics Biomarker Consumption Share by Regions in 2016
-
Figure China Metabolomics Biomarker Consumption Share by Regions in 2021
-
Figure China Metabolomics Biomarker Consumption Share by Regions in 2027
-
Table North China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table North China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure North China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure North China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure North China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table North China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table North China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure North China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure North China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure North China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table Central China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table Central China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Central China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure Central China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure Central China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table Central China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table Central China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure Central China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure Central China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table South China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table South China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure South China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure South China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure South China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table South China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table South China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure South China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure South China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure South China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table East China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table East China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure East China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure East China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure East China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table East China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table East China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure East China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure East China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure East China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table Northeast China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table Northeast China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure Northeast China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure Northeast China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table Northeast China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table Northeast China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure Northeast China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure Northeast China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table Southwest China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table Southwest China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure Southwest China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure Southwest China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table Southwest China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table Southwest China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure Southwest China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure Southwest China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table Northwest China Metabolomics Biomarker Consumption by Types from 2016 to 2027
-
Table Northwest China Metabolomics Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Metabolomics Biomarker Consumption Share by Types in 2016
-
Figure Northwest China Metabolomics Biomarker Consumption Share by Types in 2021
-
Figure Northwest China Metabolomics Biomarker Consumption Share by Types in 2027
-
Table Northwest China Metabolomics Biomarker Consumption by End-Users from 2016 to 2027
-
Table Northwest China Metabolomics Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Metabolomics Biomarker Consumption Share by End-Users in 2016
-
Figure Northwest China Metabolomics Biomarker Consumption Share by End-Users in 2021
-
Figure Northwest China Metabolomics Biomarker Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Creative Proteomics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Creative Proteomics
-
Figure Sales and Growth Rate Analysis of Creative Proteomics
-
Figure Revenue and Market Share Analysis of Creative Proteomics
-
Table Product and Service Introduction of Creative Proteomics
-
Table Company Profile and Development Status of Chenomx
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chenomx
-
Figure Sales and Growth Rate Analysis of Chenomx
-
Figure Revenue and Market Share Analysis of Chenomx
-
Table Product and Service Introduction of Chenomx
-
Table Company Profile and Development Status of Evotec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec
-
Figure Sales and Growth Rate Analysis of Evotec
-
Figure Revenue and Market Share Analysis of Evotec
-
Table Product and Service Introduction of Evotec
-
Table Company Profile and Development Status of Biocrates Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocrates Life Sciences
-
Figure Sales and Growth Rate Analysis of Biocrates Life Sciences
-
Figure Revenue and Market Share Analysis of Biocrates Life Sciences
-
Table Product and Service Introduction of Biocrates Life Sciences
-
Table Company Profile and Development Status of Ovid Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ovid Therapeutics
-
Figure Sales and Growth Rate Analysis of Ovid Therapeutics
-
Figure Revenue and Market Share Analysis of Ovid Therapeutics
-
Table Product and Service Introduction of Ovid Therapeutics
-
Table Company Profile and Development Status of Metabolon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabolon
-
Figure Sales and Growth Rate Analysis of Metabolon
-
Figure Revenue and Market Share Analysis of Metabolon
-
Table Product and Service Introduction of Metabolon
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Biomark Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biomark Diagnostics
-
Figure Sales and Growth Rate Analysis of Biomark Diagnostics
-
Figure Revenue and Market Share Analysis of Biomark Diagnostics
-
Table Product and Service Introduction of Biomark Diagnostics
-
Table Company Profile and Development Status of Human Metabolome Technologies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Human Metabolome Technologies
-
Figure Sales and Growth Rate Analysis of Human Metabolome Technologies
-
Figure Revenue and Market Share Analysis of Human Metabolome Technologies
-
Table Product and Service Introduction of Human Metabolome Technologies
-
Table Company Profile and Development Status of Metabolomic Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabolomic Diagnostics
-
Figure Sales and Growth Rate Analysis of Metabolomic Diagnostics
-
Figure Revenue and Market Share Analysis of Metabolomic Diagnostics
-
Table Product and Service Introduction of Metabolomic Diagnostics
-

Chinese